1. Campos J, Gil J, Mourão J, Peixe L, Antunes P. Ready-to-eat street-vended food as a potential vehicle of bac terial pathogens and antimicrobial resistance: An exploratory study in Porto region, Portugal. Int J Food Microbiol 2015; 3:1-6.
2. Luong T, Salabarria AC, Edwards RA, Roach DR. Standardized bacteriophage purification for personalized phage therapy. Nat Protoc 2020; 15:2867-2890.
3. Han G, Ceilley R. Chronic Wound Healing: A Review of Current Management and Treatments. Adv Ther 2017; 34:599-610.
4. Summer GJ, Puntillo KA, Miaskowski C, Green PG, Levine JD. Burn injury pain: the continuing challenge. J Pain 2007; 8:533-548.
5. Rosenkranz KM, Sheridan R. Management of the burned trauma patient: balancing conflicting priorities. Burns 2002; 28:665-669.
6. Hawkins A, Maclennan PA, McGwin JrG, Cross JM, Rue LW, 3rd. The impact of combined trauma and burns on patient mortality. J Trauma 2005; 58:284-288.
7. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev 2006; 19:403-434.
8. Hermans MH. Wounds and ulcers: Back to the old nomenclature. Wounds 2010; 22:289-293.
9. Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997; 77:637-650.
10. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14:244-269.
11. Rafla K, Tredget EE. Infection control in the burn unit. Burns 2011; 37:5-15.
12. Biswal I, Arora BS, Kasana D, Neetushree. Incidence of multidrug resistant Pseudomonas aeruginosa isolated from burn patients and environment of teaching institution. J Clin Diagn Res 2014; 8:26-29.
13. Norbury W, Herndon DN, Tanksley J, Jeschke MG, Finnerty CC. Infection in Burns. Surg Infect (Larchmt) 2016; 17:250-255.
14. Azzopardi EA, Azzopardi E, Camilleri L, Villapalos J, Boyce DE, Dziewulski P, et al. Gram negative wound infection in hospitalised adult burn patients systematic review and metanalysis. PLoS ONE 2014; 9: e95042.
15. Jiang L, Tan J, Hao Y, Wang Q, Yan X, Wang D, et al. Isolation and characterization of a novel myophage Abp9 against pandrug resistant Acinetobacater baumannii. Front Microbiol 2020; 11:506068.
16. Sedaghat A, Khadem-Rezaiyan M, Ahmadabadi A, Abbaspour H, Youssefi M, Shirzad MM, et al. Antibacterial resistance pattern of Acinetobacter baumannii in burn patients in northeast of iran. Jundishapur J Microbiol 2019; 12: e94668.
17. Antunes LCS, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 2014; 71:292-301.
18. Gordillo Altamirano F, Forsyth JH, Patwa R, Kostoulias X, Trim M, Subedi D, et al. Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials. Nat Microbiol 2021; 6:157–161.
19. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg 1998; 22: 135-145.
20. Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, Van Duin D. Bacterial Infections after burn injuries: Impact of multidrug resistance. Clin Infect Dis 2017; 65: 2130-2136.
21. Gill J, Hyman P. Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 2010; 11: 2-14.
22. Doss J, Culbertson K, Hahn D, Camacho J, Barekzi N. A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms. Viruses 2017; 9:50.
23. Naghavi NS, Golgoljam M, Akbari M. Effect of three sewage isolated bacteriophages on the multi drug resistant pathogenic bacteria. J Biol Sci 2013; 13:422-426.
24. McVay CS, Velásquez M, Fralick JA. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother 2007; 51:1934–1938.
25. Soothill J. Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections. Expert Rev Anti Infect Ther 2013; 11:909-915.
26. Rose T, Verbeken G, Vos DD, Merabishvili M, Vaneechoutte M, Lavigne R, Jennes, et al. Experimental phage therapy of burn wound infection: difficult first steps. Int J Burns Trauma 2014; 4:66-73.
27. Kumari S, Harj K, Chhibber S. Bacteriophage treatment of burn wound infection caused by Pseudomonas aeruginosa PAO in BALB/c mice. American J Biomed Sci 2009; 1:385-394.
28. Sivera Marza JA, Soothill JS, Boydell P. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients. Burns 2006; 32:644-646.
29. Lavergne S, Hamilton T, Biswas B, Kumaraswamy M, Schooley RT, Wooten D. Phage therapy for a multidrug-resistant Acinetobacter baumannii craniectomy site infection. Open Forum Infect Dis 2018; 5: ofy064.
30. Yang H, Liang L, Lin S, Jia S. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol 2010; 10:131.
31. Jin J, Li ZJ, Wang SW, Wang SM, Huang DH, Li YH, et al. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol 2012; 12:156.
32. Pallavali RR, Degati VL, Lomada D, Reddy MC, Durbaka VRP. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections. PLoS ONE 2017; 12: e0179245.
33. Mendes JJ, Leandro C, Mottola C, Barbosa R, Silva FA, Oliveira M, et al. In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections. J Med Microbiol 2014; 63:1055-1065.
34. Merabishvili M, Monserez R, van Belleghem J, Rose T, Jennes S, De Vos D, et al. Stability of bacteriophages in burn wound care products. PLoS ONE 2017;12: e0182121.
35. Goli HR, Nahaei MR, Ahangarzadeh Rezaee M, Hasani A, Samadi Kafil H, Aghazadeh M. Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran. Iran J Microbiol 2016; 8:62-69.
36. Elston HR, Baudo JA, Stanek JP, Schaab M. Multi-biochemical test system for distinguishing enteric and other gram-negative bacilli. Applied microbiology 1971; 22:408-414.
37. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991; 173:697–703.
38. De Melo ACC, da Mata Gomes A, Melo FL, Ardisson-Araújo DMP, de Vargas APC, Ely VL, et al. Characterization of a bacteriophage with broad host range against strains of Pseudomonas aeruginosa isolated from domestic animals. BMC Microbiol 2019; 19:134.
39. Huang G, Le S, Peng Y, Zhao Y, Yin S, Zhang L, et al. Characterization and genome sequencing of phage Abp1, a new phiKMV-like virus infecting multi drug resistant Acinetobacter baumannii. Curr Microbiol 2013; 66: 535-543.
40. Basak S, Singh P, Rajurkar M. Multidrug Resistant and Extensively Drug Resistant Bacteria: A Study. J pathog 2016;2016: 4065603.
41. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-281.
42. Mohammed-Ali MN, Jamalludeen NM. Isolation and characterization of bacteriophage against methicillin resistant Staphylococcus aureus. J Med Microb Diagn 2015; 5:213.
43. Ghasemi SM, Bouzari M, Shaykh Baygloo N, Chang HI. Insights into new bacteriophages of Lactococcus garvieae belonging to the family Podoviridae. Archives of virology 2014; 159:2909-2915.
44. Beheshti-Maal K, Soleimani Delfan A, Salmanizadeh S. Isolation and identification of two novel Escherichia coli bacteriophages and their application in wastewater treatment and coliform’s phage therapy. Jundishapur J Microbiol 2015; 8:1-6.
45. Yazdi M, Bouzari M, Ghaemi EA, Shahin K. Isolation, characterization and genomic analysis of a novel bacteriophage VB_EcoS-Golestan infecting multidrug-resistant Escherichia coli isolated from urinary tract infection. Scientific Rep 2020; 10:7690.
46. Bradley DE. Ultrastructure of bacteriophages and bacteriocins. Bacteriol Rev 1967; 31:230–314.
47. Van Regenmortel MHV, Mayo MA, Fauquet CM et al. Virus nomenclature: consensus versus chaos. Arch Virol 2000; 145:2227-2232.
48. Krupovic M, Dutilh BE, Adriaenssens EM, Wittmann J, Vogensen FK, Sullivan MB, et al. Taxonomy of prokaryotic viruses: update from the ICTV bacterial and archaeal viruses subcommittee. Arch Virol 2016; 161:1095-1099.
49. Zare L, Shenagari M, Khanmirzaei M A, Mojtahedi A. Isolation of lytic phages against pathogenic E.coli isolated from diabtic ulcers. Iran J Med Microbiol 2017; 11:34-41.
50. Ghasemi SM, Bouzari M, Emtiazi G. Preliminary characterization of Lactococcus garvieae bacteriophage isolated from wastewater as a potential agent for biological control of lactococcosis in aquaculture. Aquacult Int 2014; 22:1469–1480.
51. Topka G, Bloch S, Nejman-Faleńczyk B, Gąsior T, Jurczak-Kurek A, Necel A, et al. Characterization of Bacteriophage vB-EcoS-95, Isolated from Urban Sewage and Revealing Extremely Rapid Lytic Development. Front Microbiol 2019; 9:3326.
52. Fan N, Qi R, Yang M. Isolation and characterization of a virulent bacteriophage infecting Acinetobacter johnsonii from activated sludge. Res Microbiol 2017; 168:472–481.
53. O’Flaherty S, Coffey A, Edwards R, Meaney W, Fitzgerald GF, Ross RP. Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J Bacteriol 2004; 186:2862-2871.
54. Lima WG, Silva Alves GC, Sanches C, Antunes Fernandes SO, De Paiva MC. Carbapenem-resistant Acinetobacter baumannii in patients with burn injury: A systematic review and meta-analysis. Burns 2019; 45:1495-1508.
55. Jeon J, Park JH, Yong D. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia. BMC Microbiol 2019; 19:70.
56. Kusradze I, Karumidze N, Rigvava S, Dvalidze T, Katsitadze M, Amiranashvili I, et al. Characterization and testing the efficiency of Acinetobacter baumannii phage vB-GEC_Ab-M-G7 as an antibacterial agent. Front Microbiol 2016; 7:1590.
57. Shen GH, Wang JL, Wen FS, Chang KM, Kuo CF, Lin CH, et al. Isolation and characterization of ϕkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii. PLoS ONE 2012; 7: e46537.
58. Popova, AV, Zhilenkov EL, Myakinina VP, Krasilnikova VM, Volozhantsev NV. Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. FEMS Microbiology Letters 2012; 332: 40-46.
59. Yuan Y, Li X, Wang L, Li G, Cong C, Li R, et al. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity. Microb Biotechnol 2021; 14:403-418.
60. Yang H, Liang L, Lin S, Jiab SH. Isolation and Characterization of a Virulent Bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol 2010; 10:131.